Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,859 | -51,064 | -74,070 | -63,511 | -23,884 |
| Depreciation Amortization | 1,563 | 296 | -1,000 | 575 | 424 |
| Accounts receivable | -3,164 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,911 | -2,476 | 204 | 527 | 1,515 |
| Other Working Capital | 192,402 | -8,575 | 3,777 | 5,534 | 687 |
| Other Operating Activity | 12,483 | 15,864 | 19,448 | 5,256 | 3,545 |
| Operating Cash Flow | $169,336 | $-45,955 | $-51,641 | $-51,620 | $-17,714 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -944 | -79 | -1,354 | -292 |
| Purchase Of Investment | -11,366 | -14,786 | -138,954 | -102,233 | -11,846 |
| Sale Of Investment | 18,627 | 58,818 | 90,273 | 111,808 | 1,750 |
| Purchase Sale Intangibles | -12,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -12,000 | 0 | 0 | 0 | -430 |
| Investing Cash Flow | $-4,739 | $43,088 | $-48,760 | $8,221 | $-10,818 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -2 | -52 |
| Common Stock Issued | 1,619 | N/A | 111,404 | 53,457 | 32 |
| Other Financing Activity | 0 | 0 | 0 | -141 | 33,314 |
| Financing Cash Flow | $1,619 | $N/A | $111,404 | $53,315 | $33,294 |
| Exchange Rate Effect | N/A | 16 | -1 | 0 | -9 |
| Beginning Cash Position | 39,079 | 41,930 | 30,929 | 21,013 | 16,260 |
| End Cash Position | 205,295 | 39,079 | 41,930 | 30,929 | 21,013 |
| Net Cash Flow | $166,216 | $-2,851 | $11,001 | $9,916 | $4,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | 169,336 | -45,955 | -51,641 | -51,620 | -17,714 |
| Capital Expenditure | N/A | -944 | -279 | -1,354 | -292 |
| Free Cash Flow | 169,336 | -46,899 | -51,921 | -52,974 | -18,006 |